Daily non-political popular news in brief.

Widely used hepatitis B drug spurs HIV drug resistance

A Johns Hopkins study has proven false established medical practice that an antiretroviral drug widely used to treat hepatitis B liver infections was safe to use on its own in patients co-infected with HIV. Their findings demonstrate that treatment with entecavir leads to cross-resistance to other antiviral drugs used to treat the AIDS virus.

Read more »

Keywords: widely, used, hepatitis, drug, spurs, hiv, resistance, hepatiti, spur

« Previous | Next »

Similar news on "Widely used hepatitis B drug spurs HIV drug resistance":

1. Drug warning prompts treatment changes for those infected with hepatitis B and HIV
   06-20-2007 · EurekAlert!
   Cross-resistance alarms raised earlier this year by Johns Hopkins researchers about a widely used antiviral therapy for hepatitis B liver infections have prompted swift treatment revisions by the drug's maker and governmental agencies.
   Similar news · Read more »
   
2. Hepatitis B drug creates HIV resistance
   07-14-2007 · Science News Online
   A hepatitis B drug spurs resistance to HIV drugs in people infected with both diseases.
   Similar news · Read more »
   
3. Drug cocktail stops brain damage caused by HIV
   10-08-2007 · EurekAlert!
   A combination of drugs widely used to treat infections caused by HIV appears to stop brain damage caused by the virus as well, according to a study published in the Oct. 9, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
   Similar news · Read more »
   
4. 454 sequencing identifies HIV drug resistance at early stage
   06-15-2007 · EurekAlert!
   454 Life Sciences, a member of the Roche group, and a Yale School of Medicine researcher today announced that they have used the company's Genome Sequencer system to identify previously undetectable rare drug resistant HIV variants in samples from an earlier performed clinical trial.
   Similar news · Read more »
   
5. Virtual human in HIV drug simulation
   01-29-2008 · EurekAlert!
   The combined supercomputing power of the UK and US 'national grids' has enabled UCL scientists to simulate the efficacy of an HIV drug in blocking a key protein used by the lethal virus. The method -- an early example of the Virtual Physiological Human in action -- could one day be used to tailor personal drug treatments, for example for HIV patients developing resistance to their drugs.
   Similar news · Read more »
   
6. Loperamide therapy for acute diarrhea in children
   03-26-2007 · EurekAlert!
   The drug loperamide is widely used as a treatment for diarrhoea in adults, but most authorities, including the World Health Organization recommend that it should not be given to young children.
   Similar news · Read more »
   
7. Penn researchers develop new method for screening drug-resistant forms of HIV
   06-28-2007 · EurekAlert!
   Existing methods of detecting drug-resistant forms of HIV are expensive, time consuming and often fail to identify small populations of drug-resistant HIV. Now, researchers have developed a drug resistance screening method that analyzes multiple HIV variants at the same time, while also saving time and money.
   Similar news · Read more »
   
8. OHSU turns mouse into factory for human liver cells
   08-09-2007 · EurekAlert!
   Oregon Health & Science University researchers have figured out how to turn a mouse into a factory for human liver cells that can be used to test how pharmaceuticals are metabolized. The technique could soon become the standard not only for examining drug metabolism in the liver, which helps scientists determine a drug's toxicity. It also can be used as a platform for testing new therapies against liver-attacking infectious diseases, including hepatitis C and malaria.
   Similar news · Read more »
   
9. For treating malaria, less drugs may be best drugs
   11-26-2007 · EurekAlert!
   The current dosage of drugs used in treating malaria may be helping the parasites become resistant to the drugs faster, without improving the long-term outcome in patients. According to evolutionary biologists, studies using mice suggest that the optimal use of the drugs might slow the spread of drug resistance while making the patient just as healthy.
   Similar news · Read more »
   
10. The onchocerciasis parasite showing signs of resistance
    01-31-2008 · EurekAlert!
    Onchocerciasis is a parasitic infection brings about skin lesions and severe eye damage that might lead to irreversible blindness. A study published recently by IRD scientists, who monitored a cohort of patients treated with ivermectin, the sole drug used for curing infected people, found fertility-change associated genetic selection in parasite populations. Although the results do not prove with absolute certainty that Onchocerca volvulus is steadily becoming resistance to ivermectin, they do show that certain parasites are more sensitive to treatment than others.
    Similar news · Read more »